TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32577113

Group type: EXPERIMENTAL
Intervention: Automated daily text-messages regarding pain, opioid utilization, and a daily CBT intervention
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard postoperative communication limited to a two-week postoperative follow-up visit
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Automated mobile phone messaging
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Patient reported opioid utilization via software messaging system
Number of subjects: 14
Study: 35202470

Group type: EXPERIMENTAL
Intervention: Sleep disturbance (slight, moderate, or great)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Sleep disturbance levels measured at 6 months
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Sleep disturbances during weight loss from baseline to 6 months
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Food cravings and eating behaviors measured at 6 months
Number of subjects: 810
Study: 35718313

Group type: EXPERIMENTAL
Intervention: Healthy comfort food (e.g., grapes)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Unhealthy comfort food (e.g., chips)
Number of subjects: 129

Group type: COMPARATOR
Intervention: No food
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Healthy comfort food, unhealthy comfort food, and no food
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: All conditions (healthy, unhealthy, no food)
Number of subjects: 129
Study: 33276744

Group type: EXPERIMENTAL
Intervention: Music therapy (45 min once a week for 12 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Non-musical intervention (45 min once a week for 12 weeks)
Number of subjects: 80
Study: 34035312

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) 100/62.5/25 mcg via ELLIPTA
Number of subjects: 800

Group type: COMPARATOR
Intervention: Tiotropium (TIO) 18 mcg via HandiHaler
Number of subjects: 800
Study: 32039962

Group type: EXPERIMENTAL
Intervention: Parent-driven quality-improvement program including reminder calls, parent education, proactive appointment scheduling, and social media reminders
Number of subjects: 0
Study: 34233928

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study: 33212947

Group type: EXPERIMENTAL
Intervention: Fructose, Omega-3 fatty acids, and Vitamin E
Number of subjects: 0
Study: 32492727

Group type: EXPERIMENTAL
Intervention: Student instructors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clinical staff physicians
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Residents
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Attendings
Number of subjects: 100
Study: 34039302

Group type: EXPERIMENTAL
Intervention: Slow blue protocol (BP) stimulating ipRGCs
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Fast yellow protocol (YP) stimulating luminance channels
Number of subjects: 62

Group type: COMPARATOR
Intervention: Migraine occurring up to 2 weeks before testing
Number of subjects: 62

Group type: COMPARATOR
Intervention: Triptan use
Number of subjects: 62
Study: 35124187

Group type: EXPERIMENTAL
Intervention: Investigators' practices following trial discontinuation
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Investigators' sense of failure and associated negative emotions
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Systemic approach to notifying stakeholders and publishing results
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Support programs for investigators
Number of subjects: 49
Study: 34060027

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NACT) followed by cold knife conization (CKC)
Number of subjects: 13
Study: 33893516

Group type: EXPERIMENTAL
Intervention: Customized lingual brackets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional labial brackets
Number of subjects: 20
Study: 35745176

Group type: EXPERIMENTAL
Intervention: Test potato cv. SQ containing 45 mg anthocyanin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo potatoes cv. 'Haruka'
Number of subjects: 15
Study: 34116176

Group type: EXPERIMENTAL
Intervention: Ciprofol 0.4 mg/kg
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ciprofol 0.5 mg/kg
Number of subjects: 94

Group type: COMPARATOR
Intervention: Propofol 2.0 mg/kg
Number of subjects: 94
Study: 32272478

Group type: EXPERIMENTAL
Intervention: Energy Conservation Techniques (ECTs) taught over a 2-week period
Number of subjects: 32
Study: 36453709

Group type: EXPERIMENTAL
Intervention: Clazakizumab (anti-IL-6)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tocilizumab (anti-IL-6R)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34619937

Group type: EXPERIMENTAL
Intervention: Community-based comprehensive intervention (Group A)
Number of subjects: 15226

Group type: EXPERIMENTAL
Intervention: Combination of community-based comprehensive intervention and internet-based intervention (Group B)
Number of subjects: 15226
Study: 32650346

Group type: EXPERIMENTAL
Intervention: CH-EUS-FNA
Number of subjects: 148

Group type: COMPARATOR
Intervention: EUS-FNA
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Combined EUS-FNA and CH-EUS-FNA
Number of subjects: 148

Group type: COMPARATOR
Intervention: EUS-FNA and CH-EUS-FNA
Number of subjects: 148
Study: 35321743

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Exercise (HIIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate Intensity Continuous Exercise (MICT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untrained Control (UC)
Number of subjects: 0
Study: 34048716

Group type: EXPERIMENTAL
Intervention: 4 weeks of amoxicillin‐clavulanate (25‐35 mg/kg twice daily oral suspension)
Number of subjects: 106

Group type: COMPARATOR
Intervention: 2 weeks of amoxicillin‐clavulanate followed by 2 weeks of placebo
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 4 weeks of amoxicillin‐clavulanate
Number of subjects: 106
Study: 35460434

Group type: EXPERIMENTAL
Intervention: 4 weeks’ daily remote ischaemic conditioning (CRIC)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham conditioning (Control)
Number of subjects: 73
Study: 33927115

Group type: EXPERIMENTAL
Intervention: Casein protein hydrolysate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 36331944

Group type: EXPERIMENTAL
Intervention: Power motivation arousal (20 min of The Experiment)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control condition (20 min of Beautiful China documentary)
Number of subjects: 140
Study: 34042999

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 0
Study: 32951301

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 35083757

Group type: EXPERIMENTAL
Intervention: WeChat-based remote follow-up management
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional outpatient follow-up management
Number of subjects: 150
Study: 36167307

Group type: EXPERIMENTAL
Intervention: G-CSF (starting at day +3 post Auto-HSCT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No G-CSF (G-CSF withheld after Auto-HSCT)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 140

Group type: COMPARATOR
Intervention: No G-CSF
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: G-CSF and No G-CSF
Number of subjects: 140
Study: 33726828

Group type: EXPERIMENTAL
Intervention: Low-dose theophylline (200 mg ER, Unicontin-E) once daily for 52 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Low-dose theophylline (200 mg ER, Unicontin-E)
Number of subjects: 110
Study: 32969781

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (Oxy)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 10
Study: 36857968

Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg/d) and Quercetin (1250 mg/d), three consecutive days per week for three weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33901300

Group type: EXPERIMENTAL
Intervention: RMST-based approach
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 200
Study: 36198573

Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by veno‐venous extracorporeal carbon dioxide removal (vv‐ECCO2R)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by vv‐ECCO2R
Number of subjects: 412
Study: 34213869

Group type: EXPERIMENTAL
Intervention: Greater Occipital Nerve Block (GONB)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Sphenopalatine Ganglion Block (SPGB)
Number of subjects: 93
Study: 32076549

Group type: EXPERIMENTAL
Intervention: High-MUFA/low-GI diet
Number of subjects: 533

Group type: COMPARATOR
Intervention: High-SFA/high-GI diet
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Total NEFA levels
Number of subjects: 533
Study: 33516681

Group type: EXPERIMENTAL
Intervention: Web-based exercise program (3 times per week for 20 minutes over 24 weeks)
Number of subjects: 70
Study: 34332699

Group type: EXPERIMENTAL
Intervention: InterVA-4
Number of subjects: 69330

Group type: EXPERIMENTAL
Intervention: InterVA-5
Number of subjects: 69330

Group type: EXPERIMENTAL
Intervention: Physician review
Number of subjects: 69330

Group type: EXPERIMENTAL
Intervention: Physician review (India only)
Number of subjects: 69330

Group type: EXPERIMENTAL
Intervention: InterVA-4 vs InterVA-5
Number of subjects: 69330
Study: 34709013

Group type: EXPERIMENTAL
Intervention: Adductor canal block with 20 mL of ropivacaine 0.5%
Number of subjects: 183

Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 183
Study: 33217361

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (28-day interval)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (56-day interval)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (84-day interval)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo (28-day interval)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo (56-day interval)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Placebo (84-day interval)
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo (overall)
Number of subjects: 423
Study: 32730310

Group type: EXPERIMENTAL
Intervention: Lottery monetary incentive package
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fixed monetary incentive package
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waitlist (delayed monetary incentive) control group
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 35821429

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation of unstable ankle fractures
Number of subjects: 148
Study: 33387970

Group type: EXPERIMENTAL
Intervention: Acute stress exposure (Trier Social Stress Test)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Non-stress control condition (resting period)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Salivary alpha-amylase (sAA) levels in Study 1
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Cortisol levels in females in Study 2
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Lower anticipatory subjective stress responses
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Hypothetical moral decision-making
Number of subjects: 179
Study: 32734847

Group type: EXPERIMENTAL
Intervention: Inoculated with 20 μl of spore suspension (10^4 conidia per ml) from a 21-day-old PDA culture.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mock-inoculated controls with sterile water.
Number of subjects: 12
Study: 35493813

Group type: EXPERIMENTAL
Intervention: rTMS (10 Hz stimulation over the left dorsolateral prefrontal cortex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (sham stimulation)
Number of subjects: 0
Study: 35386029

Group type: EXPERIMENTAL
Intervention: Flip-chart assisted education regarding essential newborn care (ENC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Verbal advice on ENC from postnatal ward nurses
Number of subjects: 120
Study: 33487303

Group type: EXPERIMENTAL
Intervention: Magnesium treatment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 32045825

Group type: EXPERIMENTAL
Intervention: Housing First (HF) model
Number of subjects: 5631
Study: 36257876

Group type: EXPERIMENTAL
Intervention: Bursitis label plus guideline‐based advice
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Bursitis label plus treatment recommendation
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label plus guideline‐based advice
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Rotator cuff tear label plus treatment recommendation
Number of subjects: 2024

Group type: EXPERIMENTAL
Intervention: Guideline‐based advice
Number of subjects: 2024

Group type: COMPARATOR
Intervention: Treatment recommendation
Number of subjects: 2024
Study: 33441218

Group type: EXPERIMENTAL
Intervention: Energy‐balanced diet during SUSOPS (BAL)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Energy‐deficient controlled diet during SUSOPS (DEF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Energy‐balanced diet while sedentary (REST)
Number of subjects: 10
Study: 35549747

Group type: EXPERIMENTAL
Intervention: Contralaterally controlled functional electrical stimulation (CCFES)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Cyclic neuromuscular electrical stimulation (cNMES)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Task-oriented training (TOT)
Number of subjects: 129
Study: 33444369

Group type: EXPERIMENTAL
Intervention: Percentage Body Fat (PBF)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Fat Mass Index (FMI)
Number of subjects: 489
Study: 32674613

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) applied for 20 minutes.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group (stimulating device set but not turned on).
Number of subjects: 30
Study: 36137355

Group type: EXPERIMENTAL
Intervention: Perturbation treadmill with proprioception ability measured by AUC scores
Number of subjects: 60
Study: 34034686

Group type: EXPERIMENTAL
Intervention: Grade 5–6 students
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Low educational level of father
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Low educational level of mother
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Joblessness of father
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Employment of mother
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Large family size
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Use of shared articles
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Absence of bathroom in the house
Number of subjects: 480
Study: 32878613

Group type: EXPERIMENTAL
Intervention: Apalutamide 240 mg orally once-daily
Number of subjects: 68
Study: 34409858

Group type: EXPERIMENTAL
Intervention: Balstilimab alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Balstilimab in combination with zalifrelimab
Number of subjects: 0
Study: 33232912

Group type: EXPERIMENTAL
Intervention: Krill oil supplementation (400 mg EPA and DHA for 3 months, then 800 mg EPA and DHA for 9 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36349244

Group type: EXPERIMENTAL
Intervention: E-OJ-01 (400 mg/day for 8 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 32991450

Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 276

Group type: COMPARATOR
Intervention: lamivudine
Number of subjects: 276
Study: 32903142

Group type: EXPERIMENTAL
Intervention: Same-day administration of pegfilgrastim
Number of subjects: 0
Study: 33629809

Group type: EXPERIMENTAL
Intervention: EBUS combined with ROSE
Number of subjects: 152

Group type: COMPARATOR
Intervention: EBUS
Number of subjects: 152
Study: 33015888

Group type: EXPERIMENTAL
Intervention: FOLFOX
Number of subjects: 690

Group type: COMPARATOR
Intervention: 5FU
Number of subjects: 690
Study: 34057310

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 12
Study: 34341040

Group type: EXPERIMENTAL
Intervention: Current aftercare situation for women with GDM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Development of a patient-centred care model
Number of subjects: 0
Study: 34438362

Group type: EXPERIMENTAL
Intervention: Training sessions consisting of 2 ModeA tests per session (30 tests total)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Retraining sessions after 1 or 2 weeks of detraining
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ModeA test (1-minute reaction time test)
Number of subjects: 24
Study: 34193356

Group type: EXPERIMENTAL
Intervention: Haemostatic sealant
Number of subjects: 75

Group type: COMPARATOR
Intervention: Bipolar diathermy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Bilateral lesions
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Haemostatic sealant and Bipolar diathermy
Number of subjects: 75
Study: 35687807

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) components (problem solving, changing unhelpful thoughts, relaxation skills)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Barriers (being bullied, difficulty applying therapy content to new situations)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Comparisons between youth with different anxiety disorder trajectories
Number of subjects: 319
Study: 34120366

Group type: EXPERIMENTAL
Intervention: Topiramate treatment
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 308
Study: 33755143

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg daily for 48 weeks
Number of subjects: 188

Group type: COMPARATOR
Intervention: placebo for 48 weeks
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: linagliptin
Number of subjects: 188

Group type: COMPARATOR
Intervention: linagliptin and placebo
Number of subjects: 188
Study: 32692386

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (25 µg titrated to aim for serum thyrotropin levels between 0.4 and 2.5 mU/L)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (identical to levothyroxine)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 35358464

Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and low-dose dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pomalidomide and low-dose dexamethasone
Number of subjects: 0
Study: 33338679

Group type: EXPERIMENTAL
Intervention: Ologen collagen matrix (OCM) implantation during AGV surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (AGV surgery without OCM)
Number of subjects: 26
Study: 35420334

Group type: COMPARATOR
Intervention: Aspirin (placebo-controlled trial)
Number of subjects: 19114
Study: 32873953

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3, 1.68 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34916444

Group type: EXPERIMENTAL
Intervention: 300 mg Lycium barbarum polysaccharide (LBP) for 6 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 29
Study: 32165040

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Chemotherapy at Ben Taub Hospital (BTH)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Subjects enrolled in the CRYSTAL trial
Number of subjects: 103
Study: 35150407

Group type: EXPERIMENTAL
Intervention: Attention-based Long-Short-Term-Memory (LSTM) model for classification of normal/stressed trials
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Second LSTM classifier for distinguishing normal and stressed movements
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Classification of normal and stressed movements in stressed trials
Number of subjects: 30
Study: 33755145

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 32746574

Group type: EXPERIMENTAL
Intervention: Doctors
Number of subjects: 189

Group type: COMPARATOR
Intervention: Nurses, pharmacists, laboratory staff, radiology staff, and managers
Number of subjects: 189

Group type: COMPARATOR
Intervention: Different age groups
Number of subjects: 189

Group type: COMPARATOR
Intervention: Various dimensions of occupational pressure
Number of subjects: 189
Study: 35960704

Group type: EXPERIMENTAL
Intervention: EASE (Early Adolescent Skills for Emotions)
Number of subjects: 471

Group type: COMPARATOR
Intervention: EUC (Enhanced Usual Care)
Number of subjects: 471
Study: 32799841

Group type: EXPERIMENTAL
Intervention: Peripheral intravenous parenteral nutrition (P-PN)
Number of subjects: 92
Study: 35440375

Group type: EXPERIMENTAL
Intervention: Messages about interval safety, test accuracy and speed of cell changes
Number of subjects: 2931

Group type: COMPARATOR
Intervention: Control group (no additional messages)
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Being up‐to‐date with screening and previous abnormal results
Number of subjects: 2931
Study: 33886934

Group type: EXPERIMENTAL
Intervention: Resistance Training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 35738551

Group type: EXPERIMENTAL
Intervention: SRP + Er, Cr: YSGG laser
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SRP + a-PDT (methylene blue mediated antimicrobial photodynamic therapy using 660 nm diode laser)
Number of subjects: 36

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 36
Study: 35791455

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 5.0 mcg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 7.5 mcg
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 10.0 mcg
Number of subjects: 105
Study: 33151775

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbate (VitC) 2g
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (placebo, PL)
Number of subjects: 8